tiprankstipranks
Alaunos Therapeutics (DE:WEK)
FRANKFURT:WEK

Alaunos Therapeutics (WEK) Ownership - Who Owns Alaunos Therapeutics?

0 Followers

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2023Sold$2025499

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
156,446Insider155,664
744,145Insider740,424
224,282Insider223,161
372,120Insider370,259
398,050Insider396,060
9,692,403Insider9,643,941
207,434Insider206,397
72,620Insider72,257
63,965Insider63,645
200,566Insider199,563

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
49,363Institution49,116
2,181,754Institution2,170,845
100,850Institution100,346
111,142Institution110,586
9,129,740Institution9,084,091
122,715Institution122,101
110,297Institution109,746

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Alaunos Therapeutics (DE:WEK)?
Currently, no data Available
What percentage of Alaunos Therapeutics (DE:WEK) stock is held by institutional investors?
Currently, no data Available
What percentage of Alaunos Therapeutics (DE:WEK) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Alaunos Therapeutics (DE:WEK)?
Wyche Fowler owns the most shares of Alaunos Therapeutics (DE:WEK).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis